Facebook
Twitter
LinkedIn
ForwardIan Nisonson, M.D. Autism Spectrum Conference Series: Increasing Access to Early Diagnosis and Assessment of Autism Via Objective and Cost-effective Eye-tracking-based Tools
Honoring Our Founder: The Ian Nisonson, M.D. Autism Spectrum Conference Series
We are excited to announce a name change to our annual Autism lecture series, now named the Ian Nisonson, M.D. Autism Spectrum Conference Series. Initiated by Dr. Ian Nisonson 22 years ago, this series has been instrumental in raising awareness within the Medical Staff and the broader community about autism spectrum disorders. Dr. Nisonson has tirelessly championed this initiative together with Dr. Nina Sanchez, Co-director of the series, and in collaboration with local University of Miami Center for Autism and Related Disabilities (CARD) leadership to bring national experts, innovators, and key opinion leaders to our medical staff each year.
Join us for our annual Autism Spectrum lecture as our guest speaker, Ami Klin, Ph.D., addresses the challenges surrounding early diagnosis and assessment of children with autism. With the increasing prevalence of autism, it's crucial to develop strategies that ensure timely and accurate identification of the condition. Early diagnosis allows for early intervention, which can significantly improve outcomes for individuals with autism.
Dr. Klin's insights will touch on various aspects of these issues, including the need for improved screening tools, increased awareness among healthcare professionals and parents, and better access to specialized diagnostic services.
Target Audience
Pediatricians, Neurologists, Family Practice Physicians, Hospitalists, Nurses, Pharmacists, Dietitians, Athletic Trainers, Occupational Therapists, Respiratory Therapists, Social Workers and other interested healthcare professionals and members of the community.
Learning Objectives
- Recognize the early symptoms of autism and the typical priorities for treatment and intervention.
- Evaluate new advances in capitalizing eye-tracking research of early social development to generate cost-effective and community-viable solutions to increase access to early detection and diagnosis for young children with autism and related social-communication and language delays.
- Identify quantitative and cost-effective tool for the early diagnosis and assessment of autism; the clinical validation data that led to its FDA clearance for broad use in the community; and its potential for making the diagnostics process more efficient and accessible while maintaining high quality.
Ami Klin Ph.D.
Director, Marcus Autism Center, Children’s Healthcare of Atlanta
Georgia Research Alliance Eminent Scholar Professor
The Bernie Marcus Distinguished Chair in Autism
Chief, Division of Autism & Related Disorders
Department of Pediatrics, Emory University School of Medicine
Center for Translational Social Neuroscience
Atlanta, Ga.
Ami Klin, Ph.D., speaker at this educational activity, is a consultant and shareholder for EarliTec Diagnostics, and has indicated that the presentation or discussion will not include off-label or unapproved product usage. All of the relevant financial relationships listed for these individuals have been mitigated.
Michael Alessandri, Ph.D., moderator of this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Ian Nisonson, M.D., co-director of this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Nina Sanchez, M.D., co-director of this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*
*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Accreditation
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for a total of 1.5 credit hours, CE Broker Course #20-1231622, by the Florida Boards of Medicine, Osteopathic Medicine and by the Florida Council of Physician Assistants.
This activity is also approved for 1.5 credits for Nurse Practitioners, Nurses, Pharmacists and Techs, Dietitians, Athletic Trainers, Occupational Therapists, Respiratory Therapists and Clinical Social Work, Mental Health Counselor or Marriage and Family Therapies. Baptist Health South Florida CE Broker Provider #50-182.
The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.
AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Disclaimer
Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.
While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.
Available Credit
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Florida Board of Athletic Training
- 1.50 General certificate of attendance
- 1.50 Florida Board of Dietitians
- 1.50 Florida Board of Clinical Social Workers, Marriage and Family Therapists and Mental Health Counselors
- 1.50 Nurse Practitioners
- 1.50 Florida Board of Nursing
- 1.50 Florida Board of Occupational Therapy
- 1.50 Florida Board of Pharmacy
- 1.50 Florida Board of Respiratory Therapy